Trial intelligence / Profile preview

Vitamin D for BPPV Recurrence in Older Patients

NCT04578470Phase 2Unknown

Sponsor
Changi General Hospital
Start
Nov 2020
Primary completion
Nov 2022
01

Overview

Phase 2, randomised, double-blind trial (3 arms), sponsored by Changi General Hospital. Primary endpoints: Recurrence rate of Benign Paroxysmal Positional Vertigo at 2 years and Time to onset of recurrent episodes of BPPV at 2 years. Status: unknown.

Beyond the preview

Go deeper on NCT04578470.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04578470.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call